Glucocorticoids-based prodrug design: Current strategies and research progress
Attributing to their broad pharmacological effects encompassing anti-inflammation, antitoxin, and immunosuppression, glucocorticoids (GCs) are extensively utilized in the clinic for the treatment of diverse diseases such as lupus erythematosus, nephritis, arthritis, ulcerative colitis, asthma, kerat...
Saved in:
Main Authors: | Hongbing Liu (Author), Muse Ji (Author), Peifu Xiao (Author), Jingxin Gou (Author), Tian Yin (Author), Haibing He (Author), Xing Tang (Author), Yu Zhang (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Improving Breviscapine Oral Bioavailability by Preparing Nanosuspensions, Liposomes and Phospholipid Complexes
by: Zilin Song, et al.
Published: (2021) -
Development of novel liver-targeting glucocorticoid prodrugs
by: Yazheng Wang, et al.
Published: (2024) -
Editorial: Prodrug design and therapeutic applications
by: Qicai Xiao, et al.
Published: (2023) -
Current prodrug strategies for improving oral absorption of nucleoside analogues
by: Youxi Zhang, et al.
Published: (2014) -
Supersaturation induced by Itraconazole/Soluplus® micelles provided high GI absorption in vivo
by: Yue Zhong, et al.
Published: (2016)